Alteco Medical offers a medical device for extracorporeal blood purification. The product removes endotoxin (lipopolysaccharide, LPS) from the patient’s bloodstream, and is applied as an add-on therapy in sepsis to treat endotoxemia (high levels of endotoxin). This can help stabilize the patient in acute situations. Endotoxemia is often present in sepsis, a life-threatening condition and one of the most common causes of death in modern intensive care.

Quotes for Alteco Medical AB

Right Now

+/-
%
Latest
High
Low
Volume
Turnover ()
Time (Latest trade)

Board

CEO

  • Anders Althin (tf)

Chairperson of the Board

  • Mats Wahlström

Board

  • Anders Althin
  • Charlotte Althin Hicks
  • Articles of association

    • News

    Show More

    Analysis

    Largest Owners

    Name Capital % Votes % Date
    Anders Althin 90,09 90,09 2025-03-27
    Richard Ågren 0,73 0,73 2025-03-27
    Avanza Pension 0,50 0,50 2025-03-27
    Jan Aberg 0,35 0,35 2025-03-27
    Ingvar Andersson 0,31 0,31 2025-03-27
    Nordnet Pensionsförsäkring 0,30 0,30 2025-03-27
    Magnus Lundberg 0,28 0,28 2025-03-27
    Magnus Corneliusson 0,25 0,25 2025-03-27
    Handelsbanken Liv Försäkring AB 0,23 0,23 2025-03-27
    Johan Sarnmo Åberg 0,19 0,19 2025-03-27

    Insider trading

    *Source: Holdings by Modular Finance AB. Compiled and processed data from the Swedish Financial Supervisory Authority

    Key Numbers

    *Compiled data from Millistream

    Annual reports, prospectus etc.